MORTIMER IAN
CIK 1619961
Transactions on file
15
Open-market buys
1
Win rate (buys)
100%
1 scored
Avg % since filing (buys)
+1.7%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-30 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT & CEO | Buy | 30,000 | $1.12M | +1.7% | open → |
| 2025-01-27 | 2025-01-24 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Sale | 22,468 | $903.2K | -5.4% | open → |
| 2025-01-27 | 2025-01-27 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Exer. | 15,166 | $269.3K | +114.1% | open → |
| 2025-01-27 | 2025-01-27 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Sale | 1,149 | $47.2K | -7.4% | open → |
| 2025-01-27 | 2025-01-24 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Exer. | 22,468 | $399.0K | +114.1% | open → |
| 2025-01-27 | 2025-01-23 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Sale | 16,217 | $650.0K | -5.1% | open → |
| 2025-01-27 | 2025-01-23 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Exer. | 16,217 | $288.0K | +114.1% | open → |
| 2025-01-27 | 2025-01-27 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Sale | 15,166 | $613.6K | -6.0% | open → |
| 2025-01-27 | 2025-01-27 | XENE Xenon Pharmaceuticals Inc. | OfficerDirector PRESIDENT & CEO | Exer. | 1,149 | $20.4K | +114.1% | open → |
| 2025-12-09 | 2025-12-08 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT & CEO | Sale | 2,010 | $93.1K | -17.9% | open → |
| 2025-12-09 | 2025-12-08 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT & CEO | Sale | 8,820 | $402.1K | -16.6% | open → |
| 2025-12-09 | 2025-12-05 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT & CEO | Sale | 14,375 | $647.3K | -15.6% | open → |
| 2025-12-03 | 2025-11-28 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT & CEO | Sale | 97 | $4.4K | -15.5% | open → |
| 2025-10-01 | 2025-10-01 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT, CEO & INTERIM CFO | Sale | 25,000 | $1.00M | -5.3% | open → |
| 2025-10-01 | 2025-10-01 | XENE Xenon Pharmaceuticals Inc. | PRESIDENT, CEO & INTERIM CFO | Exer. | 25,000 | $192.3K | +394.4% | open → |
